Product Information
RAYALDEE ER 30 MCG CAP (HARD) is a brand product labeled by OPKO Pharmaceuticals LLC, priced at $41.2845 per EA under NDC 70301100201. Its NADAC has been published 125 times since Apr 3, 2024.
FDA first approved this application on Jun 17, 2016.
Strength
30 ug/1
Manufacturer
OPKO Pharmaceuticals LLCNDC
70301100201
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CALCIFEDIOLApproval Type
New Drug (NDA)
FDA Application
NDA208010FDA Approved
6/17/2016
On Market Since
3/11/2024
Pharmacological Classes
Price Statistics
The NADAC for RAYALDEE ER 30 MCG CAP (HARD) has been published 125 times since Apr 3, 2024, and over the history we have for it it has risen 6.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $41.2845 per EA |
|---|---|
| All-time high | $41.3026 (Jul 15, 2026) |
| All-time low | $38.8205 (Apr 3, 2024) |
| 52-week high | $41.3026 |
| 52-week low | $40.0096 |
| Median price | $40.0442 |
| Average price | $40.0396 |
| Largest weekly change | +3.0% (Jan 7, 2026) |
| Weeks tracked | 125 |
| Tracking since | Apr 3, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RAYALDEE ER 30 MCG CAP (HARD)?
The current National Average Drug Acquisition Cost (NADAC) for RAYALDEE ER 30 MCG CAP (HARD), manufactured by OPKO Pharmaceuticals LLC, is $41.2845 per EA (NDC 70301100201), effective Aug 19, 2026.
How has the price of RAYALDEE ER 30 MCG CAP (HARD) changed over time?
Over the history we have for it, the NADAC for RAYALDEE ER 30 MCG CAP (HARD) has risen 6.3%. It has been tracked across 125 weekly CMS publications since Apr 3, 2024.
What are the highest and lowest recorded NADAC prices for RAYALDEE ER 30 MCG CAP (HARD)?
Since Apr 3, 2024, the NADAC for RAYALDEE ER 30 MCG CAP (HARD) has ranged from a low of $38.8205 (Apr 3, 2024) to a high of $41.3026 (Jul 15, 2026), with a median of $40.0442 per EA.
Are there cheaper alternatives to RAYALDEE ER 30 MCG CAP (HARD)?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RAYALDEE ER 30 MCG CAP (SOFT), is $40.0351 per EA — about 3% below RAYALDEE ER 30 MCG CAP (HARD).
Who manufactures RAYALDEE ER 30 MCG CAP (HARD)?
RAYALDEE ER 30 MCG CAP (HARD) (NDC 70301100201) is labeled by OPKO Pharmaceuticals LLC, and CMS classifies it as a brand product.